- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Ekso Bionics Holdings Inc (EKSO)
Ekso Bionics Holdings Inc stock price live, this page displays NASDAQ EKSO stock exchange data. View the EKSO premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Ekso Bionics Holdings Inc real time stock price chart below.
What Is the Ekso Bionics Holdings Inc Stock Price Today?
The Ekso Bionics Holdings Inc stock price today is 10.990.
What Is the Stock Symbol for Ekso Bionics Holdings Inc?
The stock symbol for Ekso Bionics Holdings Inc is "EKSO."
What Stock Exchange Does Ekso Bionics Holdings Inc Trade On?
Ekso Bionics Holdings Inc is listed and trades on the NASDAQ stock exchange.
Is Ekso Bionics Holdings Inc a Good Stock to Buy?
Determining whether Ekso Bionics Holdings Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the EKSO quote. (ISIN: US2826444000)
What Is the Ekso Bionics Holdings Inc Stock Price Today?
The Ekso Bionics Holdings Inc stock price today is 10.990.
What Is the Stock Symbol for Ekso Bionics Holdings Inc?
The stock symbol for Ekso Bionics Holdings Inc is "EKSO."
What Stock Exchange Does Ekso Bionics Holdings Inc Trade On?
Ekso Bionics Holdings Inc is listed and trades on the NASDAQ stock exchange.
Is Ekso Bionics Holdings Inc a Good Stock to Buy?
Determining whether Ekso Bionics Holdings Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the EKSO quote. (ISIN: US2826444000)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
10.710
11.490
52 wk Range
2.730
13.500
EKSO is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
10.71011.490
52 wk Range
2.73013.500
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
EKSO Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
9.500
Downside
-13.56%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
High return over the last year
- Form 13G EKSO BIONICS HOLDINGS For: 19 March
- Investing.com
- Form 13G EKSO BIONICS HOLDINGS For: 9 April
- Investing.com
- Form 13G Ekso Bionics Holdings For: 29 January
- Investing.com
- Form DEF 14C EKSO BIONICS HOLDINGS For: 3 April
- Investing.com
- Form 13G EKSO BIONICS HOLDINGS For: 9 April
- Investing.com
- Form DEF 14C EKSO BIONICS HOLDINGS For: 3 April
- Investing.com
- Ekso Bionics CFO Wong acquires $15,499 in shares
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Neutral
Moving Averages
Sell
Ekso Bionics Holdings, Inc. designs, develops, distributes, and commercializes exoskeleton products in the Americas, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company provides EksoNR, a wearable robotic exoskeleton; Ekso Indego Therapy, a powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; and Ekso EVO, a wearable upper body exoskeleton. It also develops Ekso Nomad, a power Knee Ankle Foot Orthosis or KAFO; and MediTouch BalanceTutor rehabilitation system, a multidirectional perturbation treadmill outfitted. Ekso Bionics Holdings, Inc. was founded in 2005 and is headquartered in San Rafael, California.
Ekso Bionics Holdings Inc Earnings Call Summary for Q2/2025
- Ekso Bionics reported Q2 2025 revenue of $2.1M, down 58% YoY, with EPS of -$0.54 missing forecasts of -$0.085; stock rose 6.71% to $5.25 despite the earnings miss.
- The company posted a net loss of $2.7M ($1.24 per share) with gross profit of $800K (40% margin); cash position stands at $5.2M as of June 30, 2025.
- Personal health sector showed over 50% YTD growth; company forecasts it will surpass enterprise health revenues by 2027, with plans to close $1.4M in deferred sales.
- CEO Scott Davis emphasized AI integration as 'necessary for broader adoption of exoskeletons' and highlighted positive outcomes in securing Medicare reimbursements.
- Key challenges include federal grant uncertainties affecting enterprise health revenue, dependence on budget conversions, and potential delays in closing deferred sales.
Last Updated: 2025-11-20, 10:34 a/m
Read Full TranscriptCompare EKSO to Peers and Sector
Metrics to compare | EKSO | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipEKSOPeersSector | |
|---|---|---|---|---|
P/E Ratio | −3.3x | −7.2x | −0.5x | |
PEG Ratio | −0.08 | −0.16 | 0.00 | |
Price/Book | 4.3x | 2.4x | 2.6x | |
Price / LTM Sales | 3.1x | 3.3x | 3.2x | |
Upside (Analyst Target) | −13.6% | 58.9% | 47.4% | |
Fair Value Upside | Unlock | 16.8% | 7.7% | Unlock |
Analyst Ratings
1 Buy
1 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 9.500
(-13.56% Downside)
Earnings
Latest Release
Feb 23, 2026
EPS / Forecast
-1.46 / -0.06
Revenue / Forecast
3.14M / 6.74M
People Also Watch
FAQ
What Is the Ekso Bionics (EKSO) Stock Price Today?
The Ekso Bionics stock price today is 10.990 USD.
What Stock Exchange Does Ekso Bionics Trade On?
Ekso Bionics is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Ekso Bionics?
The stock symbol for Ekso Bionics is "EKSO."
What Is the Ekso Bionics Market Cap?
As of today, Ekso Bionics market cap is 39.160M USD.
What Is Ekso Bionics's Earnings Per Share (TTM)?
The Ekso Bionics EPS (TTM) is -4.914.
From a Technical Analysis Perspective, Is EKSO a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Ekso Bionics Stock Split?
Ekso Bionics has split 4 times.
How Many Employees Does Ekso Bionics Have?
Ekso Bionics has 53 employees.
What is the current trading status of Ekso Bionics (EKSO)?
As of Apr 25, 2026, Ekso Bionics (EKSO) is trading at a price of 10.990 USD, with a previous close of 10.830 USD. The stock has fluctuated within a day range of 10.710 USD to 11.490 USD, while its 52-week range spans from 2.730 USD to 13.500 USD.
What Is Ekso Bionics (EKSO) Price Target According to Analysts?
The average 12-month price target for Ekso Bionics is 9.500 USD, with a high estimate of 9.5 USD and a low estimate of 9.5 USD. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an -13.56% Downside potential.
What Is the EKSO Premarket Price?
EKSO's last pre-market stock price is 10.680 USD. The pre-market share volume is 110.000, and the stock has decreased by -0.150, or -1.390%.
What Is the EKSO After Hours Price?
EKSO's last after hours stock price is 11.450 USD, the stock has decreased by 0.460, or 4.190%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.